Volume 4, Number 1—March 1998
Perspective
Risk for Transfusion-Transmitted Infectious Diseases in Central and South America
Table 2
Probability of receiving an infected transfusion P(R)a and probability of getting a transfusion-transmitted infection P(I)b, by countryc
| HIV (x104) |
HBV (x104) |
HCV (x104) |
T. cruzi (x104) |
|||||
|---|---|---|---|---|---|---|---|---|
| Country | P(R) | P(I) | P(R) | P(I) | P(R) | P(I) | P(R) | P(I) |
| Bolivia | 0.64 | 0.57 | 17.27 | 12.95 | NSPd | NSP | 1096.38 | 219.28 |
| Chile | 0.00 | 0.00 | 0.26 | 0.20 | 46.46 | 41.82 | 29.36 | 5.87 |
| Colombia | 0.24 | 0.22 | 1.20 | 0.90 | 74.55 | 67.09 | 124.24 | 24.85 |
| Costa Rica | 0.00 | 0.00 | 0.45x | 0.34 | NSP | NSP | NSP | NSP |
| Ecuador | 1.05 | 0.95 | 4.52 | 3.39 | 10.33 | 9.38 | 10.29 | 2.06 |
| El Salvador | 0.00 | 0.00 | 3.23 | 2.42 | 18.87 | 16.97 | 88.75 | 17.75 |
| Guatemala | 0.00 | 0.00 | 14.28 | 10.71 | 55.26 | 49.74 | 36.75 | 7.35 |
| Honduras | 0.00 | 0.00 | 4.49 | 3.37 | 3.97 | 3.57 | 13.02x | 2.60 |
| Nicaragua | 0.00 | 0.00 | 18.95 | 14.21 | 22.70 | 20.43 | 10.48 | 2.10 |
| Paraguay | 0.00 | 0.00 | 9.32 | 6.99 | NSP | NSP | 62.37 | 12.47 |
| Peru | 0.00 | 0.00 | 0.87x | 0.65 | 20.62 | 18.56 | 247.80 | 49.56 |
| Venezuela | 0.00 | 0.00 | 1.45x | 1.09 | 71.35 | 64.21 | 13.86 x | 2.77 |
aP(R) = probability of receiving an infected transfusion = prevalence of infection x 1- level of screening; xfor countries in which reported screening level was 100%, a residual P(R) was estimated as prevalence x 1- screening sensitivity rate x 10,000.
bP(I) = probability of getting a transfusion-transmitted infection = P(R) x infectivity index (infectivity indexes used were HIV=90%; HBV=75%; HCV=90%; T.cruzi=20%). For calculations of P(R) and P(I) the prevalence was corrected taking into account the sensitivity of the screening.
cData from 1993, except for Ecuador and Paraguay, which were for 1994.
dNo screening performed, so P(R) and P(I) not known.